These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 35011736)

  • 1. Role and Involvement of TENM4 and miR-708 in Breast Cancer Development and Therapy.
    Peppino G; Riccardo F; Arigoni M; Bolli E; Barutello G; Cavallo F; Quaglino E
    Cells; 2022 Jan; 11(1):. PubMed ID: 35011736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of TENM4 as a Novel Cancer Stem Cell-Associated Molecule and Potential Target in Triple Negative Breast Cancer.
    Ruiu R; Barutello G; Arigoni M; Riccardo F; Conti L; Peppino G; Annaratone L; Marchiò C; Mengozzi G; Calogero RA; Cavallo F; Quaglino E
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33672732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The miR-30 family: Versatile players in breast cancer.
    Yang SJ; Yang SY; Wang DD; Chen X; Shen HY; Zhang XH; Zhong SL; Tang JH; Zhao JH
    Tumour Biol; 2017 Mar; 39(3):1010428317692204. PubMed ID: 28347244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated analysis of mRNA and miRNA profiles revealed the role of miR-193 and miR-210 as potential regulatory biomarkers in different molecular subtypes of breast cancer.
    Evangelista AF; Oliveira RJ; O Silva VA; D C Vieira RA; Reis RM; C Marques MM
    BMC Cancer; 2021 Jan; 21(1):76. PubMed ID: 33461524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exome Sequencing Identifies
    Xue CB; Xu ZH; Zhu J; Wu Y; Zhuang XH; Chen QL; Wu CR; Hu JT; Zhou HS; Xie WH; Yi X; Yu SS; Peng ZY; Yang HM; Hong XH; Chen JH
    Front Genet; 2018; 9():725. PubMed ID: 30745909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA A1BG-AS1 promotes tumorigenesis in breast cancer by sponging microRNA-485-5p and consequently increasing expression of FLOT1 expression.
    Cai S; Zhou Y; Pan Y; Liu P; Yu K; Chen S
    Hum Cell; 2021 Sep; 34(5):1517-1531. PubMed ID: 34115333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and functional analysis reveals
    Yi X; Li M; He G; Du H; Li X; Cao D; Wang L; Wu X; Yang F; Chen X; He L; Ping Y; Zhou D
    iScience; 2021 Sep; 24(9):103063. PubMed ID: 34568788
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of MiR-1908-3p as a novel serum biomarker for breast cancer and analysis its oncogenic function and target genes.
    Zhu Y; Wang Q; Xia Y; Xiong X; Weng S; Ni H; Ye Y; Chen L; Lin J; Chen Y; Niu H; Chen X; Lin Y
    BMC Cancer; 2020 Jul; 20(1):644. PubMed ID: 32650755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
    Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
    Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkinson's Disease in Teneurin Transmembrane Protein 4 (
    Pu JL; Gao T; Si XL; Zheng R; Jin CY; Ruan Y; Fang Y; Chen Y; Song Z; Yin XZ; Yan YP; Tian J; Zhang BR
    Front Genet; 2020; 11():598064. PubMed ID: 33414808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-promoting properties of miR-8084 in breast cancer through enhancing proliferation, suppressing apoptosis and inducing epithelial-mesenchymal transition.
    Gao Y; Ma H; Gao C; Lv Y; Chen X; Xu R; Sun M; Liu X; Lu X; Pei X; Li P
    J Transl Med; 2018 Feb; 16(1):38. PubMed ID: 29471858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ERα-miR-575-p27 feedback loop regulates tamoxifen sensitivity in ER-positive Breast Cancer.
    Liu SS; Li Y; Zhang H; Zhang D; Zhang XB; Wang X; Yu Y
    Theranostics; 2020; 10(23):10729-10742. PubMed ID: 32929377
    [No Abstract]   [Full Text] [Related]  

  • 13. LncRNA HOTTIP facilitates the stemness of breast cancer via regulation of miR-148a-3p/WNT1 pathway.
    Han L; Yan Y; Zhao L; Liu Y; Lv X; Zhang L; Zhao Y; Zhao H; He M; Wei M
    J Cell Mol Med; 2020 Jun; 24(11):6242-6252. PubMed ID: 32307830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comprehensive review on oncogenic miRNAs in breast cancer.
    Maryam M; Naemi M; Hasani SS
    J Genet; 2021; 100():. PubMed ID: 33764337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-601 is a prognostic marker and suppresses cell growth and invasion by targeting PTP4A1 in breast cancer.
    Hu JY; Yi W; Wei X; Zhang MY; Xu R; Zeng LS; Huang ZJ; Chen JS
    Biomed Pharmacother; 2016 Apr; 79():247-53. PubMed ID: 27044835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-142-3p as tumor suppressor miRNA in the regulation of tumorigenicity, invasion and migration of human breast cancer by targeting Bach-1 expression.
    Mansoori B; Mohammadi A; Ghasabi M; Shirjang S; Dehghan R; Montazeri V; Holmskov U; Kazemi T; Duijf P; Gjerstorff M; Baradaran B
    J Cell Physiol; 2019 Jun; 234(6):9816-9825. PubMed ID: 30480817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-339-5p inhibits breast cancer cell migration and invasion in vitro and may be a potential biomarker for breast cancer prognosis.
    Wu ZS; Wu Q; Wang CQ; Wang XN; Wang Y; Zhao JJ; Mao SS; Zhang GH; Zhang N; Xu XC
    BMC Cancer; 2010 Oct; 10():542. PubMed ID: 20932331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Missense mutations in TENM4, a regulator of axon guidance and central myelination, cause essential tremor.
    Hor H; Francescatto L; Bartesaghi L; Ortega-Cubero S; Kousi M; Lorenzo-Betancor O; Jiménez-Jiménez FJ; Gironell A; Clarimón J; Drechsel O; Agúndez JA; Kenzelmann Broz D; Chiquet-Ehrismann R; Lleó A; Coria F; García-Martin E; Alonso-Navarro H; Martí MJ; Kulisevsky J; Hor CN; Ossowski S; Chrast R; Katsanis N; Pastor P; Estivill X
    Hum Mol Genet; 2015 Oct; 24(20):5677-86. PubMed ID: 26188006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulatory miRNA-155, miRNA-21 target PTEN expression and activity as a factor in breast cancer development.
    Ali SA; Abdulrahman ZFA; Faraidun HN
    Cell Mol Biol (Noisy-le-grand); 2020 Oct; 66(7):44-50. PubMed ID: 33287921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer.
    Cheng CW; Wang HW; Chang CW; Chu HW; Chen CY; Yu JC; Chao JI; Liu HF; Ding SL; Shen CY
    Breast Cancer Res Treat; 2012 Aug; 134(3):1081-93. PubMed ID: 22476851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.